Di(Hydroxyethyl)Ether

Di(Hydroxyethyl)Ether

SCHEMBL10437285

C=C(C)C(=O)OOc1ccccc1.OCCOCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.41
ALDH1A1 P00352 3/20 0.41
RECQL P46063 2/20 0.41
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
HTT P42858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
KCNH3 Q9ULD8 1/20 0.34
THRB P10828 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL10716452 0.98 ELANE (0.40) ELANEALDH1A1RECQLPOLBAPEX1
Ethylene Glycol SCHEMBL2979502 0.91 ELANE (0.45) ELANEALDH1A1RECQLPOLBAPEX1
SCHEMBL632410 0.87 ELANE (0.50) ELANEALDH1A1POLBAPEX1HTT
Di(Hydroxyethyl)Ether SCHEMBL10489041 0.84 ELANE (0.58) ELANEALDH1A1RECQLPOLBAPEX1
Methacrylic Acid SCHEMBL2939572 0.84 ELANE (0.47) ELANEALDH1A1POLBAPEX1HTT
Di(Hydroxyethyl)Ether SCHEMBL22164296 0.79 ELANE (0.52) ELANEALDH1A1RECQLPOLBAPEX1
Diphenylether SCHEMBL2009809 0.79 THRB (0.49) ELANEALDH1A1RECQLPOLBAPEX1
Tetraethylene Glycol SCHEMBL22164293 0.78 ELANE (0.51) ELANEALDH1A1RECQLPOLBAPEX1
SCHEMBL16259055 0.77 ELANE (0.47) ELANEALDH1A1POLBAPEX1HTT
Methacrylic Acid SCHEMBL16353781 0.77 ALDH1A1 (0.55) ALDH1A1RECQLMTNR1AMTNR1BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119899310-A Acrylate polymer, ultraviolet-curable adhesive composition and polarizer 恒美光电股份有限公司 2025-04-29 CN claimed
CN-116635452-B Free radically polymerizable crosslinking agent, curable composition, and adhesive therefrom 3M INNOVATIVE PROPERTIES CO. (US) 2026-05-26 CN disclosed
US-12600885-B2 Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-14 US disclosed
US-12378340-B2 Crosslinkers and curable compositions including the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-08-05 US disclosed
US-20250155808-A1 RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN ZEON CORPORATION (JP) 2025-05-15 US disclosed
CN-119899310-A Acrylate polymer, ultraviolet-curable adhesive composition and polarizer 恒美光电股份有限公司 2025-04-29 CN disclosed
US-20240343951-A1 COMPOSITION INCLUDING MONOMER WITH A CARBOXYLIC ACID GROUP, MONOMER WITH A HYDROXYL GROUP, AN ALKYL MONOMER, AND CROSSLINKER AND RELATED ARTICLE AND METHOD 3M INNOVATIVE PROPERTIES COMPANY 2024-10-17 US disclosed
EP-4347673-B1 COMPOSITION INCLUDING CYCLIC IMIDE-CONTAINING MONOMER AND ORGANOBORANE COMPLEX AND RELATED ARTICLES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-10-09 EP disclosed
US-20240300216-A1 FILM-LAMINATED METAL SHEET AND METHOD OF PRODUCING THE SAME, SUBSTRATE FOR FLEXIBLE ELECTRONICS, AND ORGANIC EL SUBSTRATE JFE STEEL CORPORATION (JP) 2024-09-12 US disclosed
US-20240271021-A1 COMPOSITION INCLUDING CYCLIC IMIDE-CONTAINING MONOMER AND ORGANOBORANE COMPLEX AND RELATED ARTICLES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY 2024-08-15 US disclosed
WO-2022101701-A1 FREE-RADICALLY POLYMERIZABLE CROSSLINKER, CURABLE COMPOSITION, AND ADHESIVE THEREFROM 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-05-19 WO disclosed
EP-3983459-A1 CROSSLINKERS AND CURABLE COMPOSITIONS INCLUDING THE SAME 3M Innovative Properties Company (US) 2022-04-20 EP disclosed
WO-2022034521-A1 (METH)ACRYLATE STRUCTURAL ADHESIVES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-02-17 WO disclosed
WO-2020250154-A1 CROSSLINKERS AND CURABLE COMPOSITIONS INCLUDING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2020-12-17 WO disclosed
CN-106164190-B Coating liquid for forming transparent film and method for producing same, organic resin dispersion sol, substrate with transparent film and method for producing same 日挥触媒化成株式会社 2020-05-01 CN disclosed
US-10195133-B2 Photocurable composition for nail or artificial nail THREE BOND CO., LTD. 2019-02-05 US disclosed
US-9862866-B2 Electrically conductive adhesive composition, connection structure, solar battery module, and method for producing same HITACHI CHEMICAL COMPANY, LTD. (JP) 2018-01-09 US disclosed
US-20170157022-A1 PHOTOCURABLE COMPOSITION FOR NAIL OR ARTIFICIAL NAIL THREE BOND CO., LTD. (JP) 2017-06-08 US disclosed
US-20150255633-A1 ELECTRICALLY CONDUCTIVE ADHESIVE COMPOSITION, CONNECTION STRUCTURE, SOLAR BATTERY MODULE, AND METHOD FOR PRODUCING SAME RESONAC CORPORATION (JP) 2015-09-10 US disclosed
EP-0360617-A2 Dry toner, dry developer and process for forming images Hitachi Chemical Co., Ltd. (JP) 1990-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600885-B2 Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method RAD51, HACL2, COL2A1 ELANE 732/4885ALDH1A1 577/4885RECQL 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.